Deferred Tax Assets Operating Loss Carryforwards Net of Valuation Allowance
Edwards Lifesciences·Geographic·1 segment
Breakdown
| Segment | Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 |
|---|---|---|---|---|---|
| Other countries | $9.30M | $14.90M | $17.10M | $26.10M | $29.90M |
| Total | $9.30M | $14.90M | $17.10M | $26.10M | $29.90M |
Segments
Other countriesView metric